LISTEN LIVE

oxycontin

Purdue Pharma, the maker of the opioid drug OxyContin, has reached a tentative deal worth billions of dollars that would resolve thousands of lawsuits brought by municipal and state governments who sued the company for allegedly helping to fuel the opioid crisis.

The pending settlement likely means Purdue will avoid going to trial in the sprawling and complicated case involving some 2,300 local governments across 23 states.

Purdue Pharma Agrees To Tentative Settlement In Opioid Case

Sep 11, 2019
pills on a pharmacy shelf
Daylina Miller/WUSF Public Media

OxyContin maker Purdue Pharma reached a tentative deal Wednesday with about half the states and thousands of local governments over its role in the nation's deadly opioid epidemic, but criticism by several state attorneys general clouded prospects for an end to litigation against the company and the family that owns it.

An attorney for the company that makes the prescription opioid painkiller OxyContin says there is an opioid crisis.

A program to give naloxone overdose-antidote kits and training to front-line officers. Funding for pill disposal boxes in pharmacies, clinics and police stations across North Carolina. A radio campaign in Connecticut warning of the dangers of opioid abuse. A new medicine to treat opioid-induced constipation.

Florida’s largest health insurance company will stop covering OxyContin, the brand name for prescription opioid, beginning Jan. 1, Miami Herald reported.


This week South Carolina decided to sue the maker OxyContin for deceptive marketing.